研究项目库 / NCT02978625

Biopsy Procedure用于淋巴瘤的II 期研究

这是一项关于淋巴瘤的II 期研究,登记的药物或干预包括Biopsy Procedure;Biospecimen Collection;Computed Tomography;Laboratory Biomarker Analysis;Nivolumab;Positron Emission Mammography;Talimogene,当前状态为研究进行中,已停止招募。登记地点显示中国Los Angeles、Orange、Pasadena、Sacramento等城市有研究中心记录。是否仍有名额以及是否值得进一步询问,需要向研究中心确认。

一分钟看懂

这是一项关于淋巴瘤的II 期研究,登记的药物或干预包括Biopsy Procedure;Biospecimen Collection;Computed Tomography;Laboratory Biomarker Analysis;Nivolumab;Positron Emission Mammography;Talimogene,当前状态为研究进行中,已停止招募。登记地点显示中国Los Angeles、Orange、Pasadena、Sacramento等城市有研究中心记录。是否仍有名额以及是否值得进一步询问,需要向研究中心确认。

药物或干预

Biopsy Procedure;Biospecimen Collection;Computed Tomography;Laboratory Biomarker Analysis;Nivolumab;Positron Emission Mammography;Talimogene Laherparepvec · II 期

中国哪些地方有记录

以下地点来自登记信息,不代表此刻仍有名额;请向研究中心确认最新情况。

  • Los Angeles General Medical Center · Los Angeles
  • USC / Norris Comprehensive Cancer Center · Los Angeles
  • UC Irvine Health/Chao Family Comprehensive Cancer Center · Orange
  • Keck Medical Center of USC Pasadena · Pasadena
  • University of California Davis Comprehensive Cancer Center · Sacramento
  • UCHealth University of Colorado Hospital · Aurora
  • UM Sylvester Comprehensive Cancer Center at Aventura · Aventura
  • UM Sylvester Comprehensive Cancer Center at Coral Gables · Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach · Deerfield Beach
  • University of Miami Miller School of Medicine-Sylvester Cancer Center · Miami
  • UM Sylvester Comprehensive Cancer Center at Kendall · Miami
  • UM Sylvester Comprehensive Cancer Center at Plantation · Plantation
  • Northwestern University · Chicago
  • University of Kansas Clinical Research Center · Fairway
  • University of Kansas Cancer Center-Overland Park · Overland Park
  • University of Kansas Hospital-Indian Creek Campus · Overland Park
  • University of Kansas Hospital-Westwood Cancer Center · Westwood
  • Johns Hopkins University/Sidney Kimmel Cancer Center · Baltimore
  • Massachusetts General Hospital Cancer Center · Boston
  • Dana-Farber Cancer Institute · Boston
  • Siteman Cancer Center at Saint Peters Hospital · City of Saint Peters
  • Siteman Cancer Center at West County Hospital · Creve Coeur
  • University of Kansas Cancer Center - North · Kansas City
  • University of Kansas Cancer Center - Lee's Summit · Lee's Summit
  • University of Kansas Cancer Center at North Kansas City Hospital · North Kansas City
  • Washington University School of Medicine · St Louis
  • Siteman Cancer Center-South County · St Louis
  • University of Nebraska Medical Center · Omaha
  • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center · Lebanon
  • Rutgers Cancer Institute of New Jersey · New Brunswick

公开的入选条件

  • * Patients must have histologic or cytologic diagnosis of non-melanoma skin cancer (NMSC) or lymphomas other than B-cell lymphomas; as both of those terms are categories rather than specific diagnoses, specific guidance on eligible tumor types is provided belo
  • * PART I (before February 2020 amendment): Included tumor types
  • T cell and NK cell lymphomas, including, but not limited to: cutaneous T-cell lymphomas (CTCL), mycosis fungoides (MF), Sezary syndrome (SS), peripheral T-cell lymphoma (PTCL), ALK-positive and ALK-negative anaplastic large cell lymphoma (ALCL), and NK-cell ly
  • Merkel cell carcinoma
  • Squamous cell carcinoma of the skin, including keratoacanthomas, vulvar squamous carcinoma, and mixed histology tumors, such as basosquamous carcinoma, and squamous cell carcinoma of unknown primary consistent with skin origin
  • Other non-melanoma skin cancers
  • Basal cell carcinoma
  • Malignant sweat gland tumors, including porocarcinoma, hidradenocarcinoma, spiradenocarcinoma, cylindrocarcinoma, microcystic adnexal carcinoma and related entities, squamoid eccrine ductal carcinoma, cutaneous adenoid cystic carcinoma, digital papillary adeno

联系前需要确认

请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。

查看登记信息

登记号:NCT02978625;登记信息更新于 2026-08-13。

查看原始登记记录